Biothrax Injection, Suspension
Product Images NDC 64678-211

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Biothrax (NDC 64678-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Emergent Biodefense Operations Lansing, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Biothrax Vaccine (5mL Vial Label)

Biothrax Vaccine (5mL Vial Label)
This is a description of a vaccine called Anthrax Vaccine Adsorbed, also known as BioThrax®. The vaccine is manufactured by Emergent BioDefense in Lansing, Michigan. It is stored at 2-8°C and should not be frozen. The label indicates that it contains 5 ml, which equates to 0.5 ml per dose. The vaccine is only available via prescription and has a US license number of 1755. The text on the label instructs users to shake well before use. There are some illegible characters or symbols scattered throughout the text.*
FDA Label Image

Biothrax Vaccine (5mL Vial Carton)

Biothrax Vaccine (5mL Vial Carton)
This is a description of BioThrax®, an intramuscular vaccine used to prevent anthrax. It contains aluminum hydroxide and is manufactured in Lansing, Michigan. The package insert should be reviewed before use, and the vaccine should be stored at 28°C (36-46°F) and shaken well before administering. Each vial contains 0.5 L of the vaccine.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.